| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2007 | CA2626549A1 Small molecule inhibitors of hiv-1 capsid assembly |
| 04/26/2007 | CA2626518A1 Improved reproductive management |
| 04/26/2007 | CA2626461A1 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | CA2626449A1 Heterocyclic compounds and their use |
| 04/26/2007 | CA2626441A1 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | CA2626422A1 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | CA2626361A1 Pharmaceutical compositions and diagnostic methods for inflammatory skin diseases, disorders or conditions |
| 04/26/2007 | CA2626358A1 Pyrazoles useful in the treatment of inflammation |
| 04/26/2007 | CA2626337A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 04/26/2007 | CA2626330A1 Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-solube prodrug |
| 04/26/2007 | CA2626305A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound usedfor the purpose |
| 04/26/2007 | CA2626249A1 Use of pramipexol for treating moderate to severe restless legs syndrome (rls) |
| 04/26/2007 | CA2626181A1 Modulation of trpv expression levels |
| 04/26/2007 | CA2626105A1 Microbicidal dendrimer composition delivery system |
| 04/26/2007 | CA2626028A1 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/26/2007 | CA2626025A1 Stable pharmaceutical formulations containing escitalopram and bupropion |
| 04/26/2007 | CA2626020A1 Compounds for the treatment of atrial fibrillation |
| 04/26/2007 | CA2626009A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 04/26/2007 | CA2625988A1 Cetp inhibitors |
| 04/26/2007 | CA2625970A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 04/26/2007 | CA2625953A1 Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites |
| 04/26/2007 | CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 04/26/2007 | CA2625891A1 Inhibition of pax2 by defb1 induction as a therapy for cancer |
| 04/26/2007 | CA2625877A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 04/26/2007 | CA2625871A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/26/2007 | CA2625862A1 Liquid pharmaceutical compositions of nimodipine |
| 04/26/2007 | CA2625783A1 A1 adenosine receptor agonists |
| 04/26/2007 | CA2625762A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | CA2625722A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2625442A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2625423A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | CA2625416A1 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 04/26/2007 | CA2625362A1 Methods and compositions for the treatment of neuropsychiatric and addictive disorders |
| 04/26/2007 | CA2625341A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 04/26/2007 | CA2625189A1 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | CA2625153A1 Modulation of neurogenesis by pde inhibition |
| 04/26/2007 | CA2625112A1 Dispersible tablets comprising deferasirox |
| 04/26/2007 | CA2625047A1 Phenyl-acetamide nnrt inhibitors |
| 04/26/2007 | CA2625039A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | CA2624940A1 Compositions and methods for treatment of airway hypersecretion |
| 04/26/2007 | CA2624897A1 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 04/26/2007 | CA2624840A1 Carrier composition for nucleic acid transport |
| 04/26/2007 | CA2624837A1 Method for treating primary and secondary forms of glaucoma |
| 04/26/2007 | CA2624831A1 Biphenyl derivatives as modulators of voltage gated ion channels |
| 04/26/2007 | CA2624532A1 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | CA2624331A1 Dual-phase cement precursor systems for bone repair |
| 04/26/2007 | CA2624007A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | CA2623703A1 4-heteroarylmethyl substituted phthalazinone derivatives |
| 04/26/2007 | CA2622555A1 Dietary supplement energy-providing to skeletal muscles and protecting the cardio vascular tract |
| 04/26/2007 | CA2622545A1 Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
| 04/26/2007 | CA2622356A1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders |
| 04/26/2007 | CA2620248A1 Chromenones and their use as modulators of metabotropic glutamate receptors |
| 04/26/2007 | CA2602577A1 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 04/26/2007 | CA2599572A1 Composition for inhibition of cathepsin k |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777233A2 Gonococcal proteins and nucleic acids |
| 04/25/2007 | EP1777226A1 [1,7]naphthyridines as pde4 inhibitors |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777222A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/25/2007 | EP1777220A1 Vitamin D derivatives active on the vitamin D nuclear receptor, preparation and uses thereof |
| 04/25/2007 | EP1777219A1 1,2-Substituted naphthalene derivatives with antiglutamatergic properties and uses thereof |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1777217A1 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776982A1 Pyrimidine compounds as histamine modulators |
| 04/25/2007 | EP1776960A1 Use of collagen in combination with oxygen- and ozone-releasing perfluorocarbons for the preparation of a medicament for the treatment of skin lesions. |
| 04/25/2007 | EP1776956A1 Preventive and/or therapeutic agent for calcipenia |
| 04/25/2007 | EP1776955A1 Method and composition for the treatment of lipid and glucose metabolism disorders |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776953A1 Solid oral dosage forms comprising valsartan |
| 04/25/2007 | EP1776952A2 Photodecontamination of pathogens in blood |
| 04/25/2007 | EP1776951A1 Long chain alcohols for suppressing the concentration of C-reactive proteins (CRP) in human blood |
| 04/25/2007 | EP1776950A1 Opioid formulations for treating pain |
| 04/25/2007 | EP1776947A1 Stable oxaliplatin formulation |
| 04/25/2007 | EP1776944A1 Antimicrobial flavor and oral care composition containing the same |
| 04/25/2007 | EP1776377A2 Novel steroid agonist for fxr |
| 04/25/2007 | EP1776376A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/25/2007 | EP1776372A1 Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments |
| 04/25/2007 | EP1776371A1 A method for preparing penicillin g procaine |
| 04/25/2007 | EP1776369A1 Thienopyridone carboxamides and their medical use |
| 04/25/2007 | EP1776368A1 Inhibitors of hcv replication |
| 04/25/2007 | EP1776367A1 Synthesis of 6,7-dihydro-5h-imidazoý1,2-a¨imidazole-3-sulfonic acid amides |
| 04/25/2007 | EP1776366A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 04/25/2007 | EP1776364A2 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 04/25/2007 | EP1776363A1 Novel 6-formyltetrahydropteridines method for production and use thereof as medicament against cancer amongst other things |
| 04/25/2007 | EP1776362A1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 04/25/2007 | EP1776361A1 5-substituted 1h-pyrroloý3,2-b¨pyridines |
| 04/25/2007 | EP1776360A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases. |
| 04/25/2007 | EP1776359A2 Piperidine derivatives as renin inhibitors |
| 04/25/2007 | EP1776357A1 Hydroxyamide compounds having activity as inhibitors of histone deacetylase (hdac) |
| 04/25/2007 | EP1776356A1 Alkyl-and piperidine-substituted benzimidazole-derivates |
| 04/25/2007 | EP1776355A2 Potassium channel inhibitors |
| 04/25/2007 | EP1776352A1 Method for preparing 5-[4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h[1,2,4]triazin-2-yl]-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| 04/25/2007 | EP1776350A1 NOVEL 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF ß-SECRETASE ( BACE ) |
| 04/25/2007 | EP1776349A2 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace) |
| 04/25/2007 | EP1776346A1 1,5-diphenylpyrazoles |
| 04/25/2007 | EP1776344A2 Quinoline derivatives as neurokinin receptor antagonists |
| 04/25/2007 | EP1776343A1 Quinoline derivatives as neurokinin receptor antagonists |